Narrow search
Showing 1 - 10 of 217
Cover Image
The Effect of Bargaining Power Determinants on Pharmaceutical Prices
Linde, Sebastian - 2020
This paper provides insights into the determinants of bargaining power and how they affect drug prices. Our data show that drug prices vary across buyers and time periods. We estimate a structural bargaining model where drug suppliers and buyers engage in bilateral bargaining over drug prices....
Persistent link: https://www.econbiz.de/10012845687
Cover Image
Anti-dumping, intra-industry trade and quality reversals
Moraga-González, José Luis; Viaene, Jean-Marie - 2004
We examine an export game where two firms (home and foreign), located in two different countries, produce vertically differentiated products. The foreign firm is the most efficient in terms of R&D costs of quality development and the foreign country is relatively larger and endowed with a...
Persistent link: https://www.econbiz.de/10010261110
Cover Image
On the Heterogeneous Trade and Welfare Effects of GATT/WTO Membership
Felbermayr, Gabriel - 2020
We build on the latest developments in the structural gravity literature to quantify the partial and general equilibrium effects of GATT/WTO membership on trade and welfare. Using an extensive database covering manufacturing trade for 186 countries over the period 1980-2016, we find that the...
Persistent link: https://www.econbiz.de/10012822504
Cover Image
Trade Liberalization, Input Intermediaries and Firm Productivity : Evidence from China
Defever, Fabrice - 2019
We investigate theoretically and empirically the role of wholesalers in mediating the productivity effects of trade … liberalization. Intermediaries provide indirect access to foreign produced inputs. The productivity effects of input tariff cuts on … firms experience productivity gains from reducing input tariffs if trade intermediation of foreign inputs within their …
Persistent link: https://www.econbiz.de/10012857766
Cover Image
Regulation and Pricing of Pharmaceuticals : Reference Pricing or Price Cap Regulation?
Brekke, Kurt Richard; Grasdal, Astrid; Holmas, Tor Helge - 2021
We study the relationship between regulatory regimes and pharmaceutical firms' pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called "index pricing" for a sub-sample of off-patent pharmaceuticals, replacing the existing...
Persistent link: https://www.econbiz.de/10013316907
Cover Image
Explaining the Size Differences of Exporter Productivity Premia: Theory and Evidence
Geishecker, Ingo; Schröder, Philipp J.H.; Sörensen, Allan - 2014
Why is it that exporter productivity premia (EPP) differ so widely in size? We take this question to the theory and to … EPPs across sectors, and hence across countries, can be explained by the variation in productivity dispersion, trade costs …
Persistent link: https://www.econbiz.de/10010333430
Cover Image
A model of trade with Ricardian comparative advantage and intra-sectoral firm heterogeneity
Fan, Haichao; Lai, Edwin L.-C.; Qi, Han Steffan - 2011
still produces. In this case, the operating productivity cutoff is lowered while the exporting cutoff increases in the face …
Persistent link: https://www.econbiz.de/10010278866
Cover Image
Preferential Trade Liberalization with Endogenous Cartel Discipline: Implications for Welfare and Optimal Trade Policies
Agnosteva, Delina; Syropoulos, Constantinos; Yotov, Yoto V. - 2020
We consider an international cartel whose members interact repeatedly in their own as well as in third-country segmented markets. Cartel discipline-an inverse measure of the degree of competition between firms-is endogenously determined by the cartel's incentive compatibility constraint (ICC),...
Persistent link: https://www.econbiz.de/10012314841
Cover Image
Quantifying the Economic Effects of an EU-Japan Free Trade Agreement
Benz, Sebastian; Yalcin, Erdal - 2013
The European Union and Japan have recently launched negotiations about a bilateral free trade agreement as means of economic stimulation, with trade as a driving force to create growth and wealth. Since customs duties are already low, the success of the liberalization process hinges on the...
Persistent link: https://www.econbiz.de/10010317020
Cover Image
Dynamic Mergers Effects on R&D Investments and Drug Development Across Research Phases in the Pharmaceutical Industry
Siebert, Ralph - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D investments...
Persistent link: https://www.econbiz.de/10012833741